Clinical Trial Update: The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study [Phase 2, Phase 3]

View source ↗

Summary

A multicenter randomized trial compares an intelligent patient management model to traditional care in improving Pyrotinib medication adherence among patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: HER2 Positive Breast Cancer, Pyrotinib Treatment | Phase 2, Phase 3 | Status: RECRUITING